Shares of Recursion Pharmaceuticals ( RXRX -1.48%) fell this week. The stock lost 24% as of market close on Friday. The move ...

Palantir Technologies Inc. stock saw massive growth but now faces valuation concerns. Click for insights on PLTR's outlook, entry points, and adjusted price target.

Ooops... Something went wrong while loading this page.

Applovin Corp (NASDAQ:APP) stock closed higher by 12% on Thursday after the company reported better-than-expected ...

Utility stocks are the ultimate safe haven if you’re looking to dodge the impact of tariffs. Any new tariff announcement will ...

EPAM reported Q1 2025 results, with revenue up 11.7% YoY to $1.302B, beating estimates. Q2 outlook: $1.325B-$1.340B revenue, ...

Warning: This post contains spoilers for the first three episodes of Poker Face Season 2. Finally, Charlie Cale can stop ...

Legendary investor Warren Buffett made the surprise announcement that he will step down as CEO of Berkshire Hathaway at the ...

Among the many choices on the TSX, three names continue to stand out: Bank of Montreal ( TSX:BMO ), Canadian Utilities ( ...

Nomad Foods has revised its full-year 2025 revenue and adjusted EBITDA guidance, citing macroeconomic uncertainty and other ...

Bloomin' Brands tops Q1 EPS and sales estimates but trims Q2 outlook amid macro pressures and margin contraction.

After reporting Q1 earnings on May 5, shares of Palantir Technologies (NASDAQ:PLTR) sold-off despite beating Wall Street’s ...